Article Information
History
- December 21, 2021.
Article Versions
- You are currently viewing Version 1 of this article (December 21, 2021 - 11:49).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ameena Goga, MBChB, FC(Paeds), PhD1,2,*,
- Linda-Gail Bekker, MBChB, FCP(SA), PhD3,
- Nigel Garrett, MBBS, PhD4,5,
- Tarylee Reddy, PhD1,
- Nonhlanhla Yende-Zuma, PhD4,1,
- Lara Fairall, MBChB, PhD3,6,
- Harry Moultrie, MBBCh7,8,
- Azwidihwi Takalani, MBChB, FCPHM(SA)9,
- Valentina Trivella, MBChB10,
- Mark Faesen, FCOG (SA)10,
- Reprod Med,
- Veronique Bailey, MBChB9,
- Ishen Seocharan, BTech1,
- Glenda E Gray, MBBCH, FCPaed(SA)1 and
- on behalf of the Sisonke Study Team
- 1South African Medical Research Council, South Africa
- 2Department of Paediatrics and Child Health, School of Medicine, Faculty of Health Sciences, University of Pretoria, South Africa
- 3Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, South Africa
- 4Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
- 5School of Nursing and Public Health, Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa
- 6King’s Global Health Institute, King’s College London, UK
- 7School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 8National Institute for Communicable Diseases (NICD), Division of the National Health Laboratory Service, South Africa
- 9Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
- 10Right to Care, Johannesburg, South Africa
- ↵*Corresponding author
: Ameena Goga: Ameena.Goga{at}mrc.ac.za, South African Medical Research Council (SAMRC), Francie van Zijl Drive, Parowvallei, Cape Town; 7505 Tygerberg, South Africa
Posted December 21, 2021.
Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26.COV2.S vaccine trial, South Africa
